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Approximately 40 million people live within a 4-mile radius of waste sites that the Agency for
Toxic Substances and Disease Registry (ATSDR) has assessed to date. Human populations living
in the vicinity of such sites are often subjected to complex chemical exposures that may
contribute to the total body burden of oxogenous chemicals. Apart from the contaminants found
at waste sites, exposure may also include environmental, occupational, and personal agents.
Concurrent exposure to chemicals such as welding fumes, indoor air pollutants, tobacco smoke,
alcohol, and prescription and nonprescription drugs makes the health assessment of exposure to
waste site chemicals a more complex task. Voluntary exposures such as these frequently entail
exposures to relatively high chemical concentrations and can usually be well defined and
quantified. Conversely, involuntary exposures from waste sites may be at low concentrations and
hence difficult to characterize and quantify. Of the approximately 1450 waste sites evaluated by
the ATSDR, 530 (37%) had either completed or potentially completed exposure pathways.
Results of public health assessments conducted at 167 sites during 1993 to 1995 show that
about 1.5 million people have been exposed to site-specific contaminants. At 10% or more of the
sites that had either completed or potentially completed exposure pathways, 56 substances were
identified. Of these, 19 are either known or anticipated human carcinogens, and 9 are associated
with reproductive or endocrine-disrupting effects. In this paper we present important concerns
regarding hazardous waste sites including the impact on human health, ecology, and quality of
life. To address such human-health related issues, the ATSDR has established a mixtures
program that consists of three components: trend analysis to identify combinations of chemicals
of concern, experimental studies to identify data that would be useful in the development and
implementation of predictive decision support methodologies, and development of assessment
methodologies and guidance to provide health assessors with the tools to incorporate the
evaluation of multiple-chemical exposure into site assessments. Environ Health Perspect
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A growing number of chemicals are released more than 2.2 billion pounds of
introduced into the marketplace on a weekly toxic chemicals into the environment, a
basis. Of approximately 7 million chemicals decline in releases from previous years.
in existence, 70,000 are in current use with Although this decline in releases is a wel-
more than 1000 added each year worldwide come success of primary prevention, in cer-
(1). However, the U.S. Environmental tain instances body burdens of key
Protection Agency (U.S. EPA) reports that pollutants are noted with little insight into
in 1995 U.S. manufacturing facilities the potential for joint toxic actions of such
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chemicals at environmental levels. In sharp
contrast to the controlled conditions of
laboratory investigations, humans are typi-
cally exposed to such chemicals through
means that vary widely. A typical laboratory
study involves the controlled exposure of
experimental animals to a single chemical by
a single route for a specified period of time
(2). However, exposures normally experi-
enced by people in the vicinity of hazardous
waste sites (HWS) may be characterized as
complex exposures-involving multiple
agents and multiple pathways and patterns
of exposure dramatically different from
those typically studied in toxicologic
research (3). Such exposures may affect at-
risk populations because of elevated concen-
trations, enhanced toxicity resulting from
interactions of different chemicals complex
exposures, and possibly intrinsic physiologic
sensitivity as well. For example, because the
developing fetus is exquisitely sensitive to
the effects of such chemicals at certain time-
critical windows of exposure, certain adverse
effects on the fetus may subsequently
produce transgenerational effects (4).
Section 104(i)(5)A of the Comprehensive
Environmental Response, Compensation,
and Liability Act (CERCLA) (5) directs the
Administrator of the Agency for Toxic
Substances and Disease Registry (ATSDR)
(in consultation with the Administrator of
the U.S. EPA and agencies and programs of
the U.S. Public Health Service) to assess
whether adequate information on the
health effects of [profile] substances is avail-
able. Where adequate information is not
available, ATSDR, in cooperation with the
U.S. National Toxicology Program, is
required to assure the initiation of a pro-
gram of research designed to determine
these health effects. The statute further
directs the ATSDR: Where feasible, develop
methods to determine the health effects of
substances in combination with other sub-
stances with which they are commonly
found (5). This directive requires that the
ATSDR encourage, initiate, coordinate, and
conduct chemical mixtures research that
would advance methods development for
chemical mixtures assessment.
The human health effects and assess-
ments of environmental chemicals found at
HWS are documented in public health
assessments prepared by the agency. Other
primary concerns that impact human heath
at HWS also need to be addressed: clean-up
costs, property values, ecology, and quality
of life.
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Primary Concerns
Human Health
One of the ATSDR's primary goals is to
identify people at health risk because of
their exposure to environmental chemicals.
Although this goal can be accomplished
through the establishment of a cause-and-
effect relationship between environmental
pollutants and public health impairment
(6), causality in the face of complex expo-
sures may be difficult to establish. In such
cases a more realistic approach using
weight-of-evidence evaluation as a surro-
gate for causality has been suggested (7).
This approach allows for a broader consid-
eration of studies that investigate human
health effects at HWS that may not estab-
lish a direct causal link to adverse health
effects in exposed populations. Such a
characterization of data should be kept in
mind when considering studies of health
effects at HWS. Earlier epidemiologic
studies that were conducted to investigate
health effects in communities around
HWS failed to report statistically signifi-
cant increases in adverse health effects (8).
However, recent investigations using meta-
analysis techniques studied 593 HWS in
339 counties of 49 states, where the sole
source of water supply was contaminated
groundwater (9). For each identified
county, age-adjusted site-specific cancer
mortality rates for 13 major cancer sites
(anatomic) were extracted from U.S. cancer
mortality and trends during 1950 to 1979
for white males and during 1970 to 1979
for white females (9). Significant associa-
tions were found for cancers of the lung,
bladder, esophagus, stomach, large intes-
tine, and rectum for white males and for
cancers of the lung, breast, bladder, stom-
ach, large intestine, and rectum for white
females. Because there were no exposure
data on populations at risk of exposure to
HWS contaminant releases, these findings
should be interpreted with care.
Clearly, the array of complex exposures
on which these generalizations are based
compel a more in-depth consideration of
the health effects for populations living in
the vicinity of HWS. Such exposures may
be responsible not only for obvious adverse
health effects but also for compromised
physiologic defenses that are rendered less
effective in maintaining homeostasis. Cases
of immunosuppression in both humans
and animals for common agents such as
asbestos, tobacco smoke, benzene, toluene,
and various metals such as zinc and lead
have been well documented. Exposures to
such agents are usually concurrent. Injury,
especially to the lung, by one agent will
produce greater vulnerability to a second
agent, such as cadmium chloride followed
by inhalation of oxygen (10).
Figure 1 represents the spectrum of
biologic response to pollutant exposure
(11). At low-level exposures human popu-
lations do not show any observable health
effects; thus the chemicals remain as body
burdens having no discernable effect on the
overall health of the individuals. Physio-
logically, the body adjusts to the presence
of chemicals at this level through adaptive
mechanisms. As the pollutant exposure lev-
els increase, some effects may be observed;
but these effects, such as enzyme induction
and certain biochemical and subcellular
changes, may be of uncertain significance.
The body may have compensatory mecha-
nisms at this level of pollutant exposure
(12). However, as the levels of the pollu-
tants increase, significant readily observable
adverse effects may ensue. At these pollu-
tant levels the body has exhausted its adap-
tive and compensatory mechanisms and its
functioning could be compromised. Such
adverse effects could lead to organ function
impairment through compromise of physi-
ologic processes, leading to pathophysio-
logic changes such as fatty changes and
necrosis resulting in significant organ func-
tion impairment. Exposure to higher levels
of pollutants than these levels could thus
lead to morbidity and ultimately to death.
Exposures from the multiple sources may
cause some individuals to cross the thresh-
old for adverse health effects in this contin-
uum of effects. Considering that the
human population is normally distributed
and thus lacks homogeneity in biochemical
characteristics, some fraction of the popu-
lation will be more susceptible than others
and some fraction could be hypersensitive.
For these reasons a specific smaller fraction
of the population may be hypersensitive to
pollutant burdens and exhibit adverse
responses to levels of exposure that may
otherwise be considered low.
The contribution of hazardous waste to
exposures of populations living near HWS
may be for short periods at low levels but
may constitute a significant contribution to
overall body burdens when such exposures
are concurrent with occupational and per-
sonal exposures. The capacity for compro-
mised physiologic systems is even greater in
sensitive subpopulations [i.e., children,
women of child-bearing age, and the
elderly (5)]. In such populations pollutant
burdens can initiate pathophysiologic
Mortalityi
Adverse
Morbidity health
effects
Pathophysiologic changes
Physiologic changes of
uncertain significance
Pollutant burdens
'<- Proportion of population affected -
Figure 1. Spectrum of biologic response to environ-
mental pollutant exposure. Adapted from the American
Thoracic Society (10).
changes at lower levels in comparison to
the normal population. For example,
human infants and children differ from
adults in size, immaturity of biochemical
and physiologic functions in major body
systems and body composition in terms of
proportions of water, fat, protein, mineral
mass, and chemical constituents (13,14).
During the first 2 months of life, rapid
development occurs in the brain (cell
migration, neuron myelination, and cre-
ation of neuron synapses), lungs (develop-
ing alveoli), and bones (rapid growth and
handling). Development of the brain and
lungs continues until age 12, at which time
gonad maturation, ova and sperm matura-
tions, and breast development occur (15).
Depending on the chemical, the stage of
growth and development may be a critical
variable in evaluating the toxicity of HWS
chemicals (16).
Of particular concern are findings of
recent studies that show associations between
low-level exposures to hazardous chemicals
and developmental effects or birth defects
(17-19). Broadly defined, developmental
toxicity is any adverse effect on the develop-
ing organism from implantation through
prenatal development or postnatally to the
time of sexual maturation (20). Develop-
mental effects can be categorized as struc-
tural abnormalities, altered growth,
functional deficiencies, congenital neopla-
sia, and death of the developing organism.
Exposure to a chemical causing develop-
mental toxicity can occur to either parent
before conception, to the mother during
pregnancy, or directly to the developing
organism postnatally (e.g., via breast feed-
ing) (21). Many chemicals can cross the
placenta and concentrate in the fetus.
Thus, the developing fetus is extremely
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vulnerable to chemical exposure. In fact,
the actual concept of testing for develop-
mental toxicity requires observation of
developmental effects in a fetus without
apparent maternal toxicity.
Structural abnormalities (birth defects)
and altered growth play an important role
in developmental toxicology for several rea-
sons. They appear to be sensitive end points
to detect chemical toxicity, and they are
easier to recognize than some other effects
(e.g., subtle functional deficiencies). The
ease of recognition, however, does not nec-
essarily mean that birth defects are more
important than other end points such as
lowered intelligence quotients or chronic
alterations in the endocrine systems or
behavior. Many birth defects can be linked
to a specific period of development, thus
enabling researchers to pinpoint the win-
dow of opportunity for toxic exposure. In
laboratory settings, various patterns of
exposure timing and dosing can be tested to
obtain a whole spectrum of developmental
effects such as delayed ossifications at low
doses and skeletal malformations at high
doses. In contrast, human exposure to envi-
ronmental chemicals usually represents a
combination of exposure pathways, timing
patterns, and doses.
Susceptibility of human fetuses and
young infants to adverse health effects
caused by high-dose exposures to environ-
mental chemicals has been well docu-
mented in epidemiologic studies. For
example, mothers who consumed rice oil
accidentally contaminated by a heat
exchange fluid containing chemical mix-
tures of polychlorinated biphenyls in
Japan in 1968 (Yusho incident) and
Taiwan in 1979 (Yu-Cheng incident) had
children with developmental health effects
(22-26). Effects such as permanent
abnormalities in neurobehavioral function,
skin hyperpigmentation, decreased birth
weight, and porphyrinuria were seen in
infants exposed in utero and/or via breast
feeding (27).
Similarly, several outbreaks of mercury
poisoning have been described around the
world. In 1956 and 1960, bread made
from grain treated with fungicides con-
taining mercury was consumed by preg-
nant women in Iraq (28). Infants were
born with severe brain damage. A similar
outbreak was reported again in 1971 to
1972 (29). High mercury concentrations
were associated with the more severe effects
such as mental retardation and seizures;
lower mercury concentrations correlated
with delays in walking and talking (30,31).
In Minamata, Japan, infants exposed in
utero had severe brain damage resulting
from their mothers' consumption of
methylmercury-contaminated fish during
pregnancy (32).
Besides effects observed following
high-dose exposures to chemicals in the
environment, low-dose exposures may also
be harmful. For example, a number of
recent epidemiologic studies have demon-
strated neurobehavioral impairment at
low-dose exposure levels of lead that were
once thought to be safe. Many of these
studies have been reviewed elsewhere
(17,33,34). Reproductive effects of haz-
ardous substances released from HWS
have been extensively documented by
health investigations. Several studies have
examined associations between maternal
residence near HWS and the occurrence
of birth defects, low birth weight, and
other reproductive outcomes (35-38).
It is important to realize that humans
are exposed daily to many chemicals from
multiple sources. Low-dose exposure to
chemical mixtures may play an important
role in developmental toxicology because of
possible interactions among the compo-
nents of the mixture. The ATSDR recog-
nized these concerns and conducted or
supported several studies that investigated
low-level exposures and their correlation
with developmental effects. Some of these
studies reported on public drinking water
contamination and birth outcomes (39,40),
whereas others evaluated associations
between HWS and birth defects (18,37).
Increased risk has been reported for
neural tube defects (odds ratio [OR] = 2.1)
and heart defects (OR= 4.2) for mothers
living within one-quarter mile of a national
priorities list (NPL) site in California (37).
The authors further found increased ORs
for developmental effects in association with
maternal residence within 1 mile of NPL
sites containing selected chemical contami-
nants. For example, exposure to cyanides
and pesticides was associated with neural
Table 1. Evidence of low birth weight from studies.a
tube defects; exposure to lead, arsenic,
chromium, and 1,1,-dichloroethylene was
associated with heart defects. The authors
did not find any correlation between devel-
opment of oral cleft defects and waste site
exposures. No direct measurement of waste
site exposure was performed for the study.
The risk reported for single chemicals may
be biased because of actual exposure (i.e., to
a mixture of compounds) from the waste
sites. Further, the study did not control for
other sources of exposure to chemicals (e.g.,
industrial emissions, agricultural pesticides,
occupational exposure, etc.).
Birth weight reduction (OR= 5.1)
associated with parental residence near a
hazardous waste landfill in New Jersey has
been reported (Table 1) (18). Another
finding was an increased risk for prematu-
rity (OR= 2.1) in the exposed population
(Figure 2). The results pertain to a narrow
time period (1971 to 1975) when it is
believed the landfill exposure was the
greatest (the whole study period was from
1961 to 1985). The authors related the
magnitude of the effect to that of birth
weight reduction due to cigarette smoking
during pregnancy. The study did not con-
trol for other potential risk factors for low
birth weight such as maternal health,
cigarette and alcohol consumption during
pregnancy, parental occupation, and
parental socioeconomic status.
In a study investigating adverse preg-
nancy outcomes in relation to exposure to
volatile organic compounds from drinking
water at a U.S. Marine Corps base in North
Carolina, no effects were seen in the
exposed group as a whole (39). In associa-
tion with perchloroethylene exposure, two
susceptible subgroups were identified:
Small-for-gestational-age category was
reported in mothers over 35 years old
(OR= 3.9) and in mothers with histories of
fetal death (OR= 1.6). In association with
trichloroethylene (TCE) exposure, small-
for-gestational-age results were observed in
male offspring (OR= 3.9). However, the
Small for gestational Birthweight
Study (reference) Exposure description age (risk)b deficit, avg
NJ 94 (38) Residential proximity to Lipari landfill 5.1 -192 g
NC 97 (39) U.S. Marine Base Camp Lejeune drinking
water contaminants
Trichloroethylene 1.5 -139 g
Tetrachloroethylene 3.9C -209 gc
1.6d -51 gc
'Adapted from Berry and Bove (38). bOdds ratio. cMothers 35 years of age and older. dMothers with previous fetal
deaths.
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Figure 2. Average adjusted birth weight (grams) by
5-year time period for the years 1961 to 1985, Lipari
landfill, New Jersey. Adapted from Berry and Bove
(38). Gestational age 37 to 44 weeks.
sample size was too small and the sex-based
difference has no biologic explanation based
on known mechanisms ofTCE toxicity.
Birth outcomes in relation to drinking
water contamination in New Jersey during
1985 to 1988 have been reported by Bove
et al. (40). Exposure to several chemicals
present in drinking water was related to
developmental effects in offspring of
exposed mothers (Table 2). The strongest
relations to adverse birth outcomes were
noted for total trihalomethanes and carbon
tetrachloride. The major bias in the study
comes from possible exposure misclassifica-
tion. The study did not control for mater-
nal occupational exposure, smoking and
alcohol or drug consumption, or any other
source of chemical exposure. The authors
realize that the study, by itself, cannot
resolve whether the drinking water contam-
inants caused the adverse birth outcomes.
In summary, these studies conducted or
supported by the ATSDR are suggestive of
the following: Elevations in the rates of
neural tube defects and major cardiac
defects have been found in populations
residing in the proximity of toxic waste sites
and that consumed contaminated public
drinking water. Also, elevations in the rate
of oral cleft defects were linked to contami-
nated public drinking water. Substantial
exposures to toxic waste site contaminants
and drinking water contaminants are
related to the small-for-gestational-age cat-
egory. The possibility of adverse develop-
mental outcomes in connection with
low-dose exposure to chemical mixtures is
real. However, further studies are needed
to better define the plausible risk to future
generations. Based on the findings of the
preceding studies the impact of the evi-
dence on cancer and adverse reproductive
outcomes was summarized to Congress as
follows: "Although epidemiologic findings
are still unfolding, when evaluated in
aggregate (i.e., by combining health data
from many Superfund sites), proximity to
hazardous waste sites seems to be associated
with a small to moderate increased risk of
some kinds of birth defects and, less well
documented, some specific cancers" (41).
Quality ofLife
The ATSDR mission is "to prevent exposure
and adverse human health effects and the
diminished quality of life associated with
exposure to hazardous substances from
waste sites, unplanned releases, and other
sources of pollution present in the environ-
ment" (6). With respect to the ATSDR
mission, the quality of life of persons
exposed or potentially exposed to haz-
ardous substances in the environment may
be diminished at either end of the quality
of life continuum (42-44). The quality of
life of people living in the vicinity ofHWS
may be diminished directly and concretely
as a consequence of actual disease caused
by exposure to hazardous substances, or
indirectly as a consequence of the psy-
chologic stress caused by individuals' per-
ception of their (or their family's or
community's) increased risk for disease
occasioned by the exposure. Health asses-
sors are asked to be aware of the impor-
tance the agency places on a site's impact
on quality of life. In a public health
context, sensory impairments, neurobe-
havioral concerns, and emotional well-
being all contribute to the issue of quality
Table 2. Evidence of structural birth defects from studies in New Jersey in 1995.a
Risk, odds ratio
Central Neural tube Major cardiac Oral cleft
Exposure description nervous system defects defects defects
Carbon tetrachloride 3.8 5.4 1.0 3.6
Trichloroethylene 1.7 2.5 1.2 2.2
Tetrachloroethylene < 1.0 1.2 1.1 3.5
Dichloroethylene 2.5 2.6 < 1.0 1.7
1,2-Dichloroethane < 1.0 1.0 2.1 < 1.0
Benzene < 1.0 2.1 1.8 < 1.0
aAdapted from Bove et al. (37).
of life. Factors affecting the quality of life
for populations living near HWS have
been addressed in an ATSDR report (45).
Ecology
As a part of its health-related responsibilities
in regard to HWS, the ATSDR requested
that the National Academy of Sciences
review and evaluate whether animal epi-
demiologic studies would be useful for
human health risk assessment (46). This
effort revealed a wealth of literature that
documents the presence of environmental
contaminants in the tissues of organisms
throughout the food chain (47). In the
exposure assessment process, ATSDR
health assessors evaluate food production
as a potential source when food produc-
tion is used as a subsistence food source.
In certain areas biologic magnification via
wild plants, animals, and fish may contam-
inate a food source that constitutes a sig-
nificant portion of the diet of local
residents (48). The U.S. EPA is required
to protect human health and the environ-
ment with respect to releases or potential
releases of contaminants from abandoned
HWS (49). The national contingency
plan calls for identification and mitigation
of the environmental impacts of these sites
and the selection of remedial actions that
are "protective of environmental organ-
isms and ecosystems" (49). In response the
U.S. EPA has developed a framework for
ecologic risk assessment (50).
Exposures in Context
Human populations living in the vicinity
of HWS are often subjected to complex
chemical exposures that may contribute to
the total body burden. Apart from the con-
taminants found at waste sites, exposure
may also include environmental, occupa-
tional, and personal agents. Concurrent
exposure to chemicals such as welding
fumes, indoor air pollutants, tobacco
smoke, alcohol, and prescription and non-
prescription drugs makes the health assess-
ment of exposure to involuntary waste site
chemicals a more complex task. Voluntary
exposures such as these frequently entail
exposures to relatively high chemical con-
centrations and can usually be well defined
and quantified whereas involuntary expo-
sures from waste sites may be at low con-
centrations and hence be difficult to
characterize and quantify (Figure 3). The
figure represents a control gradient with
decreased individual control over exposures
proceeding from personal, occupational,
and environmental to hazardous waste.
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Figure 3. Human exposure near hazardous waste sites:
a control gradient with decreased individual control
over exposures proceeding from personal, occupa-
tional, and environmental to hazardous waste.
Personal exposures such as to first-hand
tobacco smoke or alcohol are voluntary.
Occupational exposure is voluntary but the
individual has less control over exposures.
The individual has few options for control-
ling environmental exposures under ordi-
nary circumstances. In most cases there are
no clear options for individual control over
hazardous waste exposures. Sometimes an
individual may not even be aware of the
site, the exposure pathways, or the nature
of the exposure. In terms of concentrations,
for normal populations personal exposures
are usually at higher levels than hazardous
waste exposures. Added to these personal
exposures are increments from occupa-
tional, environmental, and hazardous
waste exposures.
The relative magnitude of exposures is
reflected in governmental regulations and
guidelines for occupational verses environ-
mental exposures (Table 3) (51). For
example, for methylene chloride the per-
missible exposure limit (PEL) is 500 ppm
whereas the minimal risk level (MRL) is
0.4 ppm. Thus, the ratio for the PEL to
the MRL is 1250. The PEL to MRL ratio
for benzene is 20 and for TCE is 50.
Finkel et al. (52) state, "People are both
biologically unique in their sensitivity to
environmental pollutants and also environ-
mentally unique in the exposures they face
due to geography, occupation, lifestyle,
mobility patterns, and activities."
Although the U.S. EPA reports almost
a 50% decline in releases of toxic chemicals
in the past 8 years, the Toxics Release
Inventory (53) shows the number of those
chemicals classified as toxic wastes contin-
ues to rise. Recent studies on the health
effects of air pollution point to the
increased awareness that air pollution as a
mixture of chemicals must be addressed.
The components of this complex mixture
may include ozone, sulfur dioxide, and total
suspended particles (TSP), which may
include brake dust, road dust, gasoline,
diesel engine exhaust, incinerator emissions,
and coal fly ash. Recent findings show a
consistent association between air pollution
and mortality. Of particular health signifi-
cance is the TSP component of air pollu-
tion, which is itself a complex mixture (54).
Acute adverse respiratory effects of ozone
exposure are also well documented in
animal and human populations (55-57).
The National Institute for Occupational
Safety and Health has recently developed a
national occupational research agenda that
characterizes the national workforce (58).
Currently, about 125 million people are in
the U.S. workforce. In less than a decade,
this number will grow to 147 million' and
the workforce will be older and more
racially diverse. Further, more than half of
the U.S. workforce is employed indoors
and office and indoor job sectors continue
to expand. Along with the trend toward an
indoor nonindustrial workforce has been
the increase in reports of symptoms and
signs related to indoor air environments.
These range from allergic and infectious
diseases to nonspecific symptoms including
headaches and eye irritations. Although the
majority of health problems reported can-
not be attributed to specific exposures, evi-
dence suggests that multiple factors are
involved, including microbiologic, chemi-
cal, physical, and psychologic/social stres-
sors (58). The exposures to personal agents
in the environment are well known:
Tobacco, prescription and nonprescription
drugs, alcohol, herbal remedies, vitamins,
and cosmetics add to daily incremental
exposures to complex mixtures.
Completed Exposure
Pathways
Although numerous chemicals might occur
in the environment and be frequently
encountered at HWS, not all are of actual
public health concern (59,60). A method
to identify chemical mixtures of actual
public health concern has been linked to
the concept of completed exposure path-
ways (CEPs) at various HWS (61). A
CEP evaluation consists of identifying and
characterizing the following five elements:
source of contamination, environmental
medium, point of exposure, route(s) of
exposure, and a receptor population (62).
A CEP occurs when the five elements of an
exposure pathway link the contaminant
;source to receptor populations. Should a
CEP exist in the past, present, or future,
the population is considered exposed. A
potential exposure pathway exists when
one or more of the five elements are miss-
ing or if modeling is performed to replace
real sampling data (e.g., modeled ground-
water data using soil or other groundwater
data levels). For fiscal year 1996 ATSDR
investigators conducted health assessments
at sites at which more than 111,550 people
were exposed to site contaminants and
more than 59,900 people were potentially
exposed (6).
Completed Exposure Pathways
at National Priority List Sites
An analysis conducted using the ATSDR
comprehensive on-line hazardous substance
release/health effects database (HazDat)
(63) has shown that of approximately 1450
NPL sites evaluated, 530 (37%) had chemi-
cals identified in CEPs. The total number
of CEP incidents for the sites was 7244, or
about 14 incidents per site. The exposure
routes for these chemicals were as follows:
91% through groundwater, 46% through
contaminated soil, and 14% through conta-
minated biota. These numbers are larger
when potential CEPs are included in the
analysis. The top five chemicals on the CEP
site count report were TCE, lead, tetra-
chloroethylene, arsenic, and benzene (64).
The ATSDR uses CEP data to develop
toxicologic information databases, initiate
health investigations, focus toxicologic
research, and refine the agency's priority
substance list. The ATSDR lists the
chemicals to which people have been
exposed at HWS; the agency included
with the CERCLA Priority List of
Table 3. Comparison and ratio of permissible exposure limits to minimal risk levels.
PEl,a MRL,b Ratio,
Chemical ppm, TWA ppm, acute PEL/MRL
Trichloroethylene 100 2 50
Benzene 1 0.05 20
Mercury, mg/m3 0.1 0.0002 500
Toluene 200 3 67
Methylene chloride 500 0.4 1250
Vinyl chloride 1 0.5 2
Carbon tetrachloride 10 0.2 50
TWA, time-weighted average. &Occupational Safety and Health Administration (49). bChou et al. (71).
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Hazardous Substances (64) a CEP site
count report. The CEP ranking presented
in the list is based on a site frequency
count and thus lists the number of sites at
which a substance has been found in a
CEP. This information is derived from
ATSDR's public health assessments and
consultations. Because this CEP report
focuses on documented exposure, it pro-
vides an important prioritization based on
substances to which people are known to
have been exposed (64).
Once the chemicals and their mixtures
have been identified in the CEP, the signif-
icance of exposure to such chemical mix-
tures needs to be determined. This
determination is based on a multistep pub-
lic health assessment process that consists
of integrating input and conclusions of
four major components, namely, toxicity
and exposure assessment, environmental
monitoring data, health outcome data, and
community health concerns (Figure 4). To
evaluate the exposure and the toxicity of
chemicals that have been identified and
quantitated at a site, agency-derived MRLs
are used as an initial screen. Because such
evaluations could be from exposure
through multiple media, namely, water,
soil, and air, the MRLs for more than one
exposure route are used in determining the
significance of such exposures.
Agency health assessors usually conduct
a site visit to collect pertinent information.
Such site visits also involve, at times, meet-
ings with one or more of the following: the
individual members of a community living
in the vicinity of the site, community
representatives, local health officials, or
representatives of the local news media.
This information may give the health asses-
sor a basis to evaluate the conclusions of
Figure 4. Contributions to risk analysis in the determi-
nation of significant human exposure.
the toxicity assessment of the chemical
mixtures in light of the community health
concerns. Such exhaustive and complex
evaluations lead to a consideration of a full
range of potential follow-up activities and
appropriate recommendations, including
health studies, health education, research,
or establishment of registries to monitor
potentially exposed human populations.
The challenges posed by the many areas of
uncertainty involved in these evaluations
and the limited time and financial resources
available are considerable.
The ATSDR Approach
to Chemical Mixtures
Because all the possible chemical mixtures
to which human beings are potentially
exposed cannot be experimentally tested,
the ATSDR has developed a research pro-
gram in chemical mixtures. The primary
objectives of this program are to perform
a critical synthesis of relevant data and
identify generalizable rules that can be
used in site-specific assessments of health
risk following exposure to mixtures of
environmental chemicals. This research
program allows scientists to pursue vari-
ous aspects of chemical mixtures research
such as to identify environmental chemi-
cal mixtures that affect public health;
evaluate the potential for exposure of
human populations to chemical mixtures;
study the pharmacokinetic behavior of
chemical mixtures; identify various end
points that would be affected; evaluate
target organs that would be affected;
study the mechanisms of action, progres-
sion, and repair; identify biomarkers (spe-
cific and generic) that would allow the
determination of the health of an organism;
and develop qualitative and quantitative
health assessment methods for assessments
of multiple health effects.
Trend Analysis
HazDat contains environmental contami-
nation and other data from more than
3500 HWS or events with ATSDR activities
for which ATSDR has conducted public
health assessments, prepared health consulta-
tions, or provided responses to emergencies
involving releases of toxic substances into
community environments (63). HazDat also
contains information abstracted from the
toxicologic profiles on more than 200 sub-
stances most frequently encountered at
HWS. Different types of sites are encoun-
tered in the environment, such as land-
fills, municipal sites, incinerators, battery
recyclers, solvent recovery, wood treatment,
manufacturing, mining, and smelting.
Thus, HazDat can be queried for informa-
tion such as the kinds of contaminants
released from HWS into various environ-
mental media, the environmental media
that are most affected by these contami-
nants, and the pathways by which people
are exposed to the contaminants. The con-
tent and scope of HazDat allow for the
development of different approaches to the
listing of hazardous chemicals. A trend
analysis has been performed to generate a
frequency listing for the chemicals found at
HWS. Using trend analysis, a comprehen-
sive frequencies list has been generated that
used data on all NPL sites in HazDat (63).
This initial list is being used as an indicator
mixtures listing. This list provides chemi-
cals most often found in various environ-
mental media such as water, soil, or air.
The chemicals are listed within each
medium as two-, three-, and four-compo-
nent mixtures. Plans are to create specific
lists for various types of sites. Such lists can
be refined through input on toxicity, con-
centration, and pathway completion to pro-
duce a priority mixtures list. Before such
lists are finalized, potential for interaction
can also be factored. Priority mixtures can
be used for further research to understand
the toxicology of chemical mixtures, includ-
ing quantitative modeling of health effects
and further experimental testing.
Assessment
Inherent in the data analysis component of
the mixtures program is the process of
hypothesis generation. When information
is available on component chemicals and
chemical mixtures, this systematic evalua-
tion of data would permit the generation
of hypotheses that can be tested and the
identification of research needs. For indi-
vidual chemicals the available literature on
toxicity, mechanism of action, and interac-
tions with other chemicals is critically
reviewed, evaluated, and summarized in
the toxicologic profiles. Likewise it is
important to conduct similar reviews,
evaluations, assessments, and summaries
for priority mixtures, if data are available.
As numerous studies have demonstrated,
the evaluation of the joint toxicity of
chemical mixtures is a formidable chal-
lenge and not a superficial modification of
the single chemical methods (65). Those
challenges to the investigator are to con-
front the complexities involving chemical
interactions, patterns of exposure, and toxi-
city with well-conceived research proposals;
to the clinician, to identify appropriate
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biomarkers of exposure and disease resulting
from low exposures to multiple chemicals;
and to the health assessor, to apply biomed-
ical judgment to the exposure scenarios at
specific HWS.
Clearly, data gaps present the most
immediate challenge to the health assess-
ment and evaluation of chemical mixtures.
These data gaps could exist in exposure,
toxicity, or dose-response assessment
aspects of the overall evaluation. In addi-
tion to performing critical reviews of avail-
able literature, hypotheses may also be
formulated through the use of computa-
tional techniques such as structure-activity
relationships (SAR), physiologically based
pharmacokinetic (PBPK) modeling, and
progressive integration of information, that
is, binary-to-ternary-to-quaternary chemical
mixtures (if possible).
These hypotheses will be subjected to
experimental testing using in vitro or limited
in vivo studies. The results of such investiga-
tions may lead to further testing, revisions in
hypotheses, and/or the formulation of new
hypotheses. When verified, such hypotheses
would allow the development of rules that
can be generalized and applied to mixtures
of interest that have not been subjected to
testing, cannot be subjected to testing, or
used until testing data become available.
Weight-of-Evidence Methodology
The chemical mixtures toxicity assessment
typically uses the hazard index approach.
The intent of this approach is to approxi-
mate the toxicity index that would have
been calculated had the mixture itself been
tested. The critical effect for the whole
mixture is rarely known. Because of
resource limitations, a majority of the mix-
tures encountered in the environment
cannot be tested.
Hence, all plausible candidates for the
critical effects of the mixture are usually
considered by calculating, if possible,
organ-specific hazard indices. When
conducting such an exercise, it is pertinent
to consider the role of potential interac-
tions that could modify the expected out-
come when toxic chemicals occur together.
Integration of the knowledge and insights
gained about chemical interactions and the
actions of the chemical components of a
mixture become part of the weight of
evidence for interactions (66).
Quantitative Modeling
Development of alternative risk assessment
procedures and models is a complex data-
intensive task; paucity of data is frequently
the bottleneck to developing potential
hazard-assessment methods or models of
risk assessment of chemical mixtures such
as interaction prediction. Thus, experi-
mental research is sponsored to obtain
data to elucidate toxicologic mechanisms,
to better understand the molecular toxi-
cology of chemicals, particularly their
mechanisms of interaction, and to estab-
lish quantitative models. From the outset,
such research should identify the following
elements that could contribute to the toxi-
city of the chemical mixture(s): identifica-
tion of multiple target organs; defining
internal doses through toxicokinetics
(absorption, distribution, metabolism,
receptor binding, and elimination); con-
sidering all information on assessments,
biomonitoring, biomarkers, adducts, and
metabolites; and evaluating mechanisms of
interaction, the levels at which they occur,
and their significance at environmental
levels. It is also important that the labora-
tory investigator, the model developer, and
the risk assessor work in a collaborative
relationship to ensure that the animals or
test system, doses and dosing regimen, and
other variables of the experimental proce-
dure have been selected based on existing
data and experimental design that will
address existing data gaps.
Experimental Testing
In the current environment of austere
resource allocations and heightened
awareness of animal use in toxicologic
research, more pragmatic experimental
testing methods must be used without
compromising the sensitivity or specificity
obtained through classical methods.
Efforts should take into consideration all
options available, including recently
developed innovative techniques. To this
extent significant advances have been
made in alternative toxicologic testing
methods such as in vitro testing, PBPK
modeling, and biologically based dose-
response modeling. Positive correlations
have been noted between in vitro activity
and in vivo potency. Thus, several in vitro
assays validated with in vivo studies are
available to conduct toxicant interaction
studies. Even though most of these tests are
still in various investigatory phases, they
have been studied enough to obtain initial
estimates of dose-response relationships for
mixtures of chemicals.
For certain specific end points of
concern, it may be feasible to develop a
screen of tests to study interactions using
these assays. The underlying assumption is
that if biologic activity in these tests is well
correlated with in vivo toxic potency, inter-
action coefficients measured using such
screening tests may be similarly correlated.
The plausibility of such assumptions
must be further established by highly
focused parallel studies involving the
results from in vitro testing, limited animal
testing, and theoretical studies to assure the
inclusions of biologic and pharmacokinetic
processes that are important to the in vivo
expression of toxicity. Because many of the
examples of chemical compound interac-
tions are pharmacokinetically based, this
problem may be substantially complicated
for mixtures.
Nevertheless, in vitro test systems-
particularly those that use in vitro metabolic
activating systems-may permit screening
many important combinations of chemi-
cals, which would not otherwise be possi-
ble, especially for receptor-based or other
toxicodynamic interactions. Coupled with
pharmacokinetic modeling, these systems
may serve as the best practical approach for
detecting interactions and using this infor-
mation in the health assessment process.
A selection of mixtures for the in vitro
assays to identify a broad range of interac-
tion coefficients could prove beneficial to
the ultimate goal of predicting interactions.
Based on the in vitro results, in vivo mea-
surements could be made in a subsequent in
vivo validation study for such mixtures that
cover the same range of observed interaction
coefficients. Before the results of subsequent
in vitro assays in estimating or predicting
joint effects of chemical mixtures can be
used with confidence, a strong link must be
established between in vitro and in vivo
assay correlations and between in vitro and
in vivo measured interaction coefficients.
Based on the advances in our under-
standing of the mechanisms of toxicity, an
experimental parallelogram design has
been recently advanced that allows care-
fully planned and goal-oriented research
to be conducted (Figure 5). This design
allows multispecies comparisons as well as
extrapolation to human populations. As a
first step, in vitro rodent species bioassays
(rats, mice, or hamsters) are conducted to
test the toxic effects of chemicals. Results
from such studies are validated in in vivo
rodent studies. These studies are then
followed with in vitro studies with human
systems (e.g., human cell lines) to evaluate
the findings of the animal studies. Thus, the
in vitro rodent studies are used to confirm
the initial in vivo rodent findings and these
results are subsequently confirmed in vitro
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Rodents-in vivo > Humans-in vivo
PBPK models
Testable prediction Extrapolation
Rodents-in vitro | Humans-in vitro
In vitro models
Figure 5. Parallelogram for in vitro-in vivo extrapola-
tion between animals and humans. Adapted from
Himmelstein et al. (64).
in human systems. The information thus
generated is used to extrapolate the potential
effects of the chemicals to human popula-
tions. Using this design, humans have been
shown to be more like rats and less like mice
regarding metabolism of 1,3-butadiene
(67). Based on this comparative data,
Himmelstein et al. (67) suggest that because
the concentration of butadiene epoxide, the
active moiety, will be low in humans, the
human cancer risk following exposure to
butadiene will be similarly low. However, if
this assessment was based only on mouse
data, the risk would be incorrectly estimated
as higher than the current estimate. This
experimental design is also useful for the
study of toxicity of chemical mixtures under
various conditions of exposure.
With the intent to help support
development of chemical mixtures assess-
ment methods, the ATSDR has initiated a
range of toxicity testing and research
efforts in cooperation with the National
Institute of Environmental Health
Sciences, the private sector, and academic
institutions. These activities are geared
toward limited in vivo and in vitro studies
using various currently available testing
assays and methods. Similarly, SAR can be
used to extend our range of plausible infer-
ence and extrapolation within and across
chemical classes. Although no single assay
screen or method is likely to provide all
necessary information, such approaches in
aggregate can provide significant insights
about the overall public health implications
of exposure to multiple chemicals.
Conclusion
Because site interventions ranging from
education of people regarding their risks to
site remediation require extensive time and
human and monetary resources, it is
imperative that the risks at HWS be accu-
rately characterized. Agencies are increas-
ingly using a decision framework that
involves risk-based priorities with the
objective of implementing prevention mea-
sures to protect the people potentially
exposed to hazardous materials (68).
However, once the hazards have been accu-
rately characterized, it is equally important
that risks to public health be skillfully com-
municated. This phase of the intervention
process is pivotal because the perception of
risk is often not consistent with the real
risks to public health (69).
A critical element in producing accurate
health assessments is the availability of
relevant data. Often the public health
assessment process is forced to rely on
limited availability of adequate scientific
information. Thus, in the public health
assessment process an evaluation of com-
plex exposures may devolve into an evalua-
tion based on data derived from studies
entailing time-weighted average exposures
to single chemicals by single routes and
short-term exposure scenarios (70). Such
evaluations are not able to address the
potential for chemical interactions and the
aggregate contribution to body burdens.
Hence, ATSDR research is focused on the
reduction of uncertainties resulting from
the absence of critical data. An array of
innovative tools that have been used suc-
cessfully in pharmacology and medicine are
increasingly finding acceptance in the
health risk assessment community. These
tools may allow for accurate assessments of
the potential for adverse health effects from
exposure to environmental chemicals and
their mixtures, thereby leading to a reduc-
tion of uncertainty in the risk characteriza-
tion process. Tools such as SAR modeling
and PBPK/pharmacodynamic modeling
can find utility in the decision-making
process and the performance of risk charac-
terization. The ATSDR is supporting work
at a number of research and educational
institutions as well as collaborating with
industry to develop these methods into
useful tools in the assessment of chemical
mixtures and to facilitate their use in the
mainstream of public health practice.
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